Market Currents
Monday, November 16, 2009
8:00 AM
Email this
-
Bristol-Myers (BMY) says it will spin off its stake in its nutritionals division, Mead Johnson (MJN), in a deal that could net as much as $6.5B. Earlier this year, Bristol-Myers sold 17% of Mead Johnson in an IPO offering.